bcbs fep glp-1 coverage 2025 insurance worsened at start of 2025, report says Zepbound Covered by Bcbs Virginia

If you have chronic kidney disease, heart failure, liver disease, or take medications that affect electrolyte balance (such as diuretics, ACE inhibitors, or NSAIDs), discuss electrolyte supplementation with your doctor before starting

For patients with coexisting depression and obesity, naltrexone/bupropion can be considered first-line pharmacotherapy due to the antidepressant properties of bupropion, which functions as a noradrenalin and dopamine reuptake inhibitor (119)

If everything goes well, we should be able to submit a new drug application for market approval by the end of 2027 or 2028, he adds

Mar 25, 2026 As more employees work through treatment or return after cancer, employers have an increasingly meaningful role in supporting their well-being

This is the real deal

Endocrinologists and cardiologists in major cities are gaining experience with GLP-1 medications through diabetes management applications, facilitating confidence in prescribing for obesity indications